Raxone®

Active substance Idebenone
Holder Santhera Pharmaceuticals
Status Running
Indication Patients with Duchenne Muscular Dystrophy (DMD) who completed DELOS study (SNT-III-003/ EudraCT 2009-012037-30)
Public documents Approbation
Information for the patient
Informed consent
Last update 03/12/2014
Last updated on 14/12/2017